API Holdings Limited is an integrated healthcare and technology company whose ecosystem includes PharmEasy, pharmaceutical distribution, hospital supply and diagnostic services. The group connects consumers, pharmacies, healthcare institutions and diagnostic customers through technology-enabled healthcare platforms and nationwide distribution infrastructure.
API Holdings Limited is an integrated healthcare and health-technology company best known for its PharmEasy consumer platform. The group operates across multiple parts of India's healthcare value chain, combining pharmaceutical distribution, consumer healthcare, hospital supplies, diagnostic services and technology-enabled healthcare solutions.
The business has evolved from the founders' early efforts to solve inefficiencies in pharmaceutical demand and distribution. Ascent was established as a pharmaceutical distribution business, while PharmEasy was subsequently developed as a technology-powered consumer healthcare marketplace. API Holdings Private Limited was incorporated in 2019 and later became the principal holding company for the broader ecosystem. Following its conversion into a public limited company, its name changed to API Holdings Limited.
The group's product revenue is generated primarily through the distribution of pharmaceutical, OTC, surgical, consumable and private-label products. Its distribution network serves retail pharmacies, chemists, institutions and hospitals. Retailio provides technology that helps connect pharmaceutical wholesalers and pharmacies, while the Aknamed business addresses healthcare and hospital supply requirements.
On the consumer side, PharmEasy provides a digital platform through which users can access medicines and other healthcare products as well as diagnostic services. The group's services business also includes diagnostics, technology-platform licensing, fulfilment and related healthcare services. Thyrocare forms an important part of the group's diagnostic ecosystem and operates a large diagnostic testing and franchise network.
The company was co-founded by Siddharth Shah, Dharmil Sheth, Dr. Dhaval Shah, Hardik Dedhia and Harsh Parekh. The current senior leadership includes Rahul Guha as Managing Director and Chief Executive Officer, Siddharth Shah as Co-Founder, Executive Director and Vice Chairman, and Alok Kumar Jagnani as Whole-Time Director and Group Chief Financial Officer.
API Holdings' operating model combines physical pharmaceutical supply-chain infrastructure with digital platforms and healthcare services. This allows the group to participate across both business-to-consumer and business-to-business healthcare markets. Its revenue base includes pharmaceutical and healthcare-product distribution, consumer fulfilment, hospital supplies, diagnostics and technology-related services.
Investors researching API Holdings unlisted shares or PharmEasy unlisted shares should distinguish the legal company from the PharmEasy brand. The equity security generally traded in the unlisted market is an equity share of API Holdings Limited rather than a direct equity share in a separate company named PharmEasy. Accordingly, an API Holdings unlisted share price or PharmEasy share price quotation should be assessed with reference to API Holdings Limited, the security's ISIN, the company's capital structure and the number of shares outstanding.
VaultStreet Advisors believes investors evaluating API Holdings equity shares or other unlisted/pre-IPO securities should independently assess the security type, valuation, financial performance, dilution risk and liquidity. Unlisted securities can carry materially different risks from listed shares, and investors should understand the exact instrument being purchased before completing a transaction.
| Period | Revenue (₹ Cr) | EBITDA (₹ Cr) | PAT (₹ Cr) | EPS (₹) |
|---|---|---|---|---|
| FY2026 | 6,618.50 | 99.90 | -520.29 | -0.37 |
| FY2025 | 5,872.20 | -179.10 | -1,572.39 | -1.05 |
Figures in ₹ crore unless stated otherwise, as reported by the company.
Tell us the company and quantity you are interested in. We confirm current availability and the live price.
We share a quote covering price per share, total consideration and settlement timeline, so there are no surprises.
Provide your Client Master Report along with PAN and address proof so the transfer can be initiated to your demat account.
Transfer the funds to the account named on our contact page. Shares are delivered to your demat account on settlement.
Tell us the quantity you are looking for and we will come back with current availability, a firm price and the settlement timeline.
Talk to VaultStreet
Gamma Rotors Limited is an Indian defence and aerospace technology company engaged in the development and manufacturing of unmanned aerial vehicles (UAVs), drones and related advanced systems.
B9 Beverages offering bold, flavorful craft beer experiences
Motilal Oswal Home Finance Limited is an affordable housing finance company focused on providing home finance solutions to low- and middle-income families, including first-time homebuyers across urban, semi-urban and emerging markets in India. A subsidiary of Motilal Oswal Financial Services Limited, the company operates through a branch-led housing finance network supported by digital processes and credit underwriting capabilities.
